Enouri S, Monteith G, Johnson R. Characteristics of myogenic reactivity in isolated rat mesenteric veins. Am J Physiol Regul Integr Comp Physiol 300: R470 -R478, 2011. First published December 1, 2010; doi:10.1152/ajpregu.00491.2010.-Mechanisms of mechanically induced venous tone and its interaction with the endothelium and key vasoactive neurohormones are not well established. We investigated the contribution of the endothelium, L-type voltage-operated calcium channels (L-VOCCs), and PKC and Rho kinase to myogenic reactivity in mesenteric vessels exposed to increasing transmural pressure. The interaction of myogenic reactivity with norepinephrine (NE) and endothelin-1 (ET-1) was also investigated. Pressure myography was used to study isolated, cannulated, third-order rat mesenteric small veins and arteries. NE and ET-1 concentration response curves were constructed at low, intermediate, and high transmural pressures. Myogenic reactivity was not altered by nitric oxide synthase inhibition with N -nitro-L-arginine (L-NNA; 100 M) or endothelium removal in both vessels. L-VOCCs blockade (nifedipine, 1 M) completely abolished arterial tone, while only partially reducing venous tone. PKC (chelerythrine, 2.5 M) and Rho kinase (Y27632, 3 M) inhibitors largely abolished venous and arterial myogenic reactivity. There was no significant difference in the sensitivity of NE or ET-1-induced contractions within vessels. However, veins were more sensitive to NE and ET-1 when compared with corresponding arteries at low, intermediate, and high transmural pressures, respectively. These results suggest that 1) myogenic factors are important contributors to net venous tone in mesenteric veins; 2) PKC and Rho activation are important in myogenic reactivity in both vessels, while L-VOCCs play a limited role in the veins vs. the arteries, and the endothelium does not appear to modulate myogenic reactivity in either vessel type; and 3) mesenteric veins maintain an enhanced sensitivity to NE and ET-1 compared with the arteries when studied under conditions of changing transmural distending pressure. myogenic tone; myogenic responses; mesenteric small arteries; signal transduction; vasoactive agents THE PREVAILING LEVEL OF VASOMOTOR tone within a segment of the circulation is controlled primarily by sympathetic neurogenic influences, intrinsic myogenic properties of the vascular smooth muscle (VSM), and key local or circulating humoral factors (16, 32, 38) . Varying contributions from these factors, in part, provide functional specialization of the veins vs. the arteries in a particular vascular bed while enabling the cardiovascular system to meet the changing demands of the body. Several studies conducted in veins including facial, saphenous, portal, skeletal muscle, and bat wing (3, 6, 7, 15, 18) have described myogenic tone in these vessels. However, the strength of myogenic tone varies between veins, being dependent on the function of the vascular bed and its contribution to venous capacitance. Pressure-induced myogenic tone in rat saphenous vein is capable of controlling ϳ30% of its total capacity, being greatly affected by acute and chronic hemodynamic loads on the vessel wall (32, 33). Brookes and Kaufman (4) were able to demonstrate development of myogenic tone in fourth-order rat mesenteric venules. The mesentery represents the largest capacitance bed in the body comprising ϳ 25% of total circulating blood volume (38, 39). Importantly, only relatively small increases in active vascular tone of a major venous capacitance bed are required to significantly alter venous return and cardiovascular function (32).This underscores the potential importance of myogenic tone in overall venomotor tone in the low pressure venous system, as well as the hemodynamic consequences that may occur from altered venous myogenic reactivity in cardiovascular diseases, such as orthostatic hypotension (34).Currently, there remains a substantial paucity of work exploring the origin and mechanisms responsible for development of myogenic tone in veins, and the contribution of myogenic factors to integrated venous function. Undoubtedly this is due, in no small part, to the significant technical challenges associated with studying the more delicate and thin-walled small veins and venules under conditions of distending pressure. Failure to detect venous myogenic tone in most experiments may be the result of vulnerability of the wall of the small veins (32).
THE PREVAILING LEVEL OF VASOMOTOR tone within a segment of the circulation is controlled primarily by sympathetic neurogenic influences, intrinsic myogenic properties of the vascular smooth muscle (VSM), and key local or circulating humoral factors (16, 32, 38) . Varying contributions from these factors, in part, provide functional specialization of the veins vs. the arteries in a particular vascular bed while enabling the cardiovascular system to meet the changing demands of the body. Several studies conducted in veins including facial, saphenous, portal, skeletal muscle, and bat wing (3, 6, 7, 15, 18) have described myogenic tone in these vessels. However, the strength of myogenic tone varies between veins, being dependent on the function of the vascular bed and its contribution to venous capacitance. Pressure-induced myogenic tone in rat saphenous vein is capable of controlling ϳ30% of its total capacity, being greatly affected by acute and chronic hemodynamic loads on the vessel wall (32, 33) . Brookes and Kaufman (4) were able to demonstrate development of myogenic tone in fourth-order rat mesenteric venules. The mesentery represents the largest capacitance bed in the body comprising ϳ 25% of total circulating blood volume (38, 39) . Importantly, only relatively small increases in active vascular tone of a major venous capacitance bed are required to significantly alter venous return and cardiovascular function (32) .This underscores the potential importance of myogenic tone in overall venomotor tone in the low pressure venous system, as well as the hemodynamic consequences that may occur from altered venous myogenic reactivity in cardiovascular diseases, such as orthostatic hypotension (34) .Currently, there remains a substantial paucity of work exploring the origin and mechanisms responsible for development of myogenic tone in veins, and the contribution of myogenic factors to integrated venous function. Undoubtedly this is due, in no small part, to the significant technical challenges associated with studying the more delicate and thin-walled small veins and venules under conditions of distending pressure. Failure to detect venous myogenic tone in most experiments may be the result of vulnerability of the wall of the small veins (32) .
Alterations in VSM membrane potential and intracellular calcium levels cannot fully explain venous myogenic reactivity (33, 45, 50) . In limited studies, inhibitors of PKC and Rho kinase, key regulatory molecules of VSM calcium sensitization, have been shown to abolish stretch-activated myogenic tone in rabbit facial veins using wire myography, but no studies have used pressurized vessels (8, 27) . Using isolated thirdorder branches of mesenteric vessels and state-of-the-art pressure myography, the results of our study are the first to provide insight into the mechanisms of pressure-induced myogenic tone in a large-capacitance bed such as the mesentery, and to uncover important differences in mechanical mechanisms of vasomotor tone in veins compared with arteries. In the present study, we hypothesized that pressurized third-order mesenteric veins would develop myogenic tone to increasing distending pressure and that Rho kinase and PKC would play a pivotal role in pressure-induced vascular tone.
Splanchnic veins have a high population of adrenergic receptors and are therefore very sensitive to adrenergic stimulation compared with arteries. Norepinephrine (NE) released by the peripheral sympathetic nervous system and local and systemic hormones including angiotensin II and endothelial-derived nitric oxide (NO), prostanoids, and endotelin-1 (ET-1) may interact with myogenic factors to affect overall vasomotor tone (1, 2, 13, 25, 49) . To evaluate interactions between myogenic factors and pharmacomechanical coupling, we also studied the effects of changing transmural distending pressure on concentration responses to NE and ET-1, two major vasoactive agents released from the sympathetic nerve terminals and endothelium, respectively. It was hypothesized that the veins would show enhanced sensitivity to the contractile effects of ET-1 and NE compared with the arteries across the range of distending pressures studied. The site of modulation of myogenic reactivity by vasoactive agonists may occur at the level of the receptor (42) . However, angiotensin II, NE, and ET-1 also share common cellular pathways in contracting VSM. Interactions between these vasoactive agents and myogenic factors may result from links to common signaling pathways, as well as changes in membrane potential that could modulate the level of vasomotor tone (25, 26, 28) . To our knowledge the effect of changing transmural distending pressure on NE or ET-1-induced contractions of mesenteric veins has not been studied.
MATERIALS AND METHODS
Animals. Healthy male Sprague-Dawley rats (Charles River, Quebec, ON, Canada) weighing 288.2 Ϯ 2.5 g (mean Ϯ SE) were used in this study. Rats were housed in a humidity and temperature-controlled room with a 12:12-h light-dark cycle and given standard chow and access to water ad libitum. All animal experiments were approved by the Institutional Animal Care and Use Committee of the University of Guelph and conformed to standards set forth by the Canadian Council on Animal Care.
Preparation of mesenteric small veins and arteries. Rats were euthanized by an intraperitoneal injection of pentobarbital sodium (50 mg/ kg; CEVA Santé Animal, Libourne, France). The ileum (10 cm) and associated mesentery were removed and placed in cold (4°C, pH 7.35-7.40) Krebs' physiological salt solution. Third-order mesenteric small veins (ID, 213.7 Ϯ 6.4 m at 4 mmHg, n ϭ 57) or small arteries (ID, 220.7 Ϯ 4.5 m at 60 mmHg, n ϭ 55) ϳ 2-3 mm in length were isolated by removing the adhering fat and connective tissue. The order of the mesenteric veins and arteries was identified according to branching order with the major vein or artery supplying the mesentery being the first-order and subsequent branches being numbered accordingly.
Pressure myography. Following dissection, vessels were mounted on the inflow and outflow glass cannulas (tip diameter, 100 -150 m) of a myograph vessel chamber [Danish Myotechnology (DMT); Aarhus, Denmark] and secured with 11-0 nylon suture. Cannulated veins or arteries were then placed on the stage of an inverted microscope (Nikon Instruments, Melville, NY). To ensure that blood and metabolites were removed, mesenteric veins or arteries were perfused for 20 min at a physiological flow rate of 2 l/min and 20 l/min, respectively. Simultaneously, vessels were continually superfused with warmed (37.0 Ϯ 0.5°C), oxygenated (95% O 2-5% CO2) Krebs' solution at a rate of 7 ml/min by using a peristaltic pump (Minipuls 3 peristaltic pump, Gilson). Mesenteric vessels were visualized by a black and white camera attached to an inverted microscope for continuous monitoring of changes in vessel diameter, and data were obtained by Diamtrak software (Adelaide, Australia) allowing for a resolution of 0.5-m diameter changes. All experiments were performed in pressurized mesenteric veins and arteries under conditions of no intraluminal flow, with all drugs provided in the superfusing solution in known concentrations.
Experimental protocols. In all experiments, the viability of the vessel for study was assessed by a contractile response to NE (10 M). The integrity of the endothelium was assessed by a dilator response to acetylcholine (1 M) and bradykinin (0.1 M) in NE preconstricted arteries and veins, respectively. Vessels that were unable to react adequately to NE, acetylcholine, or bradykinin or demonstrated pressure leaks were discarded. Before each experiment, all vessels were allowed to equilibrate for a period of 30 min at a transmural pressure of 4 mmHg and 60 mmHg for mesenteric veins and arteries, respectively. Myogenic reactivity in vessels is comprised of two phenomena: 1) myogenic responses, which involve alterations in vascular tone resulting in decreases in vessel diameter in response to a change in distending pressure; and 2) myogenic tone, which involves maintaining vascular tone at a constant level of distending pressure (45) . Vascular tone may be measured in pressurized vessels in vitro as the difference in vessel diameter under active conditions (presence of calcium in media) vs. passive relaxed conditions (calciumfree media) obtained at the same distending pressure (4) . Mesenteric arteries that did not develop spontaneous myogenic responses during equilibration were also not studied. In the total of 139 vessels we isolated for study, eight veins and 19 arteries were discarded either for failing viability testing with NE or the arteries did not develop spontaneous myogenic responses during equilibration. No significant difference was noted with the baseline ID of small veins across experiments. Similarly, vessel size was also not different between small arteries across each experiment. It should also be mentioned that only one vessel per rat was used for each experimental protocol throughout the study.
In the first set of experiments, following stabilization, mesenteric vessels were pressurized from 2 to 12 mmHg (increments of 2 mmHg) in veins and 20 to 140 mmHg (increments of 20 mmHg) in arteries. Each pressure step was maintained for 10 min in veins and 5 min in arteries to allow the vessel to reach a steady-state diameter and data were continuously recorded by use of Diamtrak software. Control experiments were conducted in mesenteric vessels with an intact endothelium using calcium containing Krebs' solution. To confirm that the endothelium remained viable for the duration of the control experiments, we retested endothelial integrity at its completion and found no differences in vasodilatory responses to bradykinin or acetylcholine before or after control experiments in either veins or arteries, respectively (data not shown). In a subset of experiments, the endothelium was either pharmacologically blocked by use of N -nitro-L-arginine (L-NNA, 100 M) (36) or mechanically removed by perfusing the arteries with 1 ml of air (48) or passing a piece of hair of appropriate size through the lumen of veins (preliminary work in our laboratory). The absence of the endothelium was confirmed by loss of the dilator response to acetylcholine or bradykinin in NE preconstricted arteries and veins, respectively. Additionally, to ensure that this procedure did not damage smooth muscle cell function, vessel responses to NE were evaluated before and after removal of the endothelium, and showed no significant differences (data not shown).
In a second set of experiments, nifedipine (1 M) (50, 57), chelerythrine (2.5 M) (46), or Y-27632 (3 M) (12, 17, 44, 51) was applied to the superfusing solution. These drug concentrations were chosen based on previous studies and initial preliminary work done in our laboratory. Vessel responses to increasing transmural pressure were evaluated following a 30-min incubation period for each inhibitor and in the continued presence of the inhibitors. Following each experiment, passive pressure response curves were generated by changing the superfusing medium to a calcium-free Krebs' solution, which was prepared by replacing CaCl2 with EGTA (2 mM). To confirm specificity of PKC and Rho kinase inhibitors on myogenic reactivity, we compared contractile responses to NE (10 M) and KCl (120 mM) prior to incubation with inhibitors to contractile responses obtained at the end of the experiment in the continued presence of the inhibitors. No significant differences were noted, in either arteries or veins, with contractile responses to NE (10 M) or KCl (120 mM) prior to application of Y27632 at 3 M compared with responses obtained at the end of the experiment in the continued presence of the inhibitor (Table 1) . However, contractile responses to NE (10 M) and KCl (120 mM) were significantly reduced following application of chelerythrine at 2.5 M in both arteries and veins, with responses to NE being more reduced than KCl responses (P Ͻ 0.05) ( Table 1) . Therefore, we completed an additional set of experiments in vessels with chelerythrine at 1 M and found no significant differences with NE (10 M) or KCl (120 mM) contractile responses before applica-tion of the inhibitor vs. contractile responses obtained at the end of the experiment.
In the final set of experiments, following equilibration, NE (10
Ϫ11
M to 10 Ϫ4 M) and ET-1 (10 Ϫ13 M to 10 Ϫ8 M) concentration response curves (CRC) were obtained in mesenteric veins with distending pressures fixed at 2, 6, and 12 mmHg; and arteries at 20, 60, and 120 mmHg. These pressure levels were chosen as representative of low, intermediate, and high physiological transmural pressures based on previous work in mesenteric vessels by others (9, 21) . NE and ET-1 were applied in increasing and known concentrations to the superfusing solution. Each agonist concentration was applied for 5 min to allow adequate time to reach a steady-state response. A 20-min washout period was observed between successive applications of each NE concentration, whereas ET was applied in a cumulative manner due to its pseudo-irreversible receptor binding. Statistical analysis. Changes in vessel inner (ID) and outer diameters (OD) were measured in micrometers. Wall thickness was calculated by subtracting vessel OD from ID at low, intermediate, and high transmural pressures. The wall-to-lumen ratio (h/R) was calculated from measurement of wall thickness and expressed as a ratio of the vessel diameter. Vascular compliance, the ratio of change in the vessels' inner diameter (⌬ID) to an associated change in transmural pressure (⌬P), was calculated in mesenteric small veins and arteries at physiological transmural pressures ranges of 4 -8 mmHg and 40 -80 mmHg using calcium-free Krebs' solution, respectively. Agonistinduced contractions were expressed as a percentage of the initial resting diameter (baseline) of the vessel. Agonist concentration producing EC 50 and maximum contraction (Emax) for NE and ET-1 were determined for each CRC fitted to a four-parameter logistic equation (OriginLab 8.0; OriginLab, Northampton, MA). The EC50 values are reported as pD2 values, which are the negative logarithm (Ϫlog) of the EC50 concentrations. Statistical analysis was performed by two-way ANOVA for repeated measures followed by a post hoc Tukey's or Dunnett's test (SAS 9.1.3; SAS Institute, Cary, NC). The contractile responses to NE (10 M) and KCL (120 mM) prior to incubation with chelerythrine and Y27632 and at the completion of the experiment in the continued presence of the inhibitors were analyzed by one-way ANOVA for repeated measures. The assumptions of the ANOVA were assessed by comprehensive residual analysis. To meet the assumptions of the ANOVA and to handle percentage data, log or logit transforms were applied, when appropriate. At the end of the experiment where chelerythrine (2.5 M) was applied, the reduction in the contractile responses to NE (10 M) was compared with that of KCL (120 mM) by use of a paired t-test. Data are expressed as means Ϯ SE and P values Ͻ 0.05 were considered significant.
RESULTS
Role of the endothelium in pressure-induced activation of myogenic reactivity. Third-order mesenteric veins did not demonstrate myogenic responses; however, these vessels were able to develop significant myogenic tone that appeared greatest over the low-to-intermediate pressure ranges (Figs. 1-4) . Values are means Ϯ SE; n ϭ number per group in parenthesis. P Ͻ 0.05, *compared with control; †compared with corresponding KCl value in presence of chelerythrine (2.5 M). Compared with veins, mesenteric arteries of the same branching order developed both myogenic tone and myogenic responses following stepwise increases in transmural pressure, with myogenic responses beginning at 80 mmHg and persisting to the highest pressure tested (Figs. 1-4) . Inhibition of NOS with L-NNA (100 M) did not significantly affect the magnitude of myogenic reactivity in either veins or arteries with increasing pressure compared with control responses (Fig. 1) . However, vascular tone tended to be greater in L-NNA-treated veins and arteries compared with controls, and vascular tone was significantly greater in L-NNA-treated veins at 8 -12 mmHg compared with passive responses, while comparable responses in control veins were not different from passive responses. Myogenic reactivity was also not different in denuded veins (n ϭ 5) or arteries (n ϭ 5) compared with intact vessels (data not shown). Additionally, there was no significant difference in responses obtained in L-NNA-treated veins and arteries compared with denuded veins and arteries, respectively (data not shown).
Role of extracellular calcium in pressure-induced activation of myogenic reactivity. To investigate the contribution of extracellular calcium influx through L-VOCCs to myogenic reactivity, mesenteric vessels were pretreated with nifedipine, and responses to stepped increases in transmural pressure were obtained. Nifedipine (1 M) resulted in a significant, but incomplete, loss of venous myogenic tone; however, responses to pressure increases in veins under passive conditions were significantly different from responses obtained in nifedipinetreated veins (Fig. 2) . By contrast, nifedipine completely abolished all myogenic reactivity in arteries, with no differences noted between responses obtained under passive conditions vs. responses in the presence of nifedipine (Fig. 2) .
Role of PKC and Rho kinase in pressure-induced activation of myogenic reactivity.
To study the contribution of VSM PKC and Rho kinase activation to myogenic reactivity, the PKC inhibitor chelerythrine and the Rho kinase inhibitor Y27632 were individually applied to mesenteric veins and arteries. Chelerythrine (2.5 M) and Y27632 (3 M) completely abolished all myogenic reactivity that developed subsequent to increased transmural pressure in mesenteric arteries (Figs. 3  and 4) . Similar findings were noted in the veins with Y27632 (Fig. 4) . However, some myogenic tone remained in chelerythrine-treated mesenteric veins at a distending pressure of 6 mmHg, as evidenced by a significant difference between responses obtained under passive conditions (ID, 401.1 Ϯ 9.1) vs. responses in the presence of chelerythrine (ID, 361.8 Ϯ 11.1) (P ϭ 0.0165). Myogenic reactivity was not significantly affected by 1 M chelerythrine in either arteries or veins at any of the pressure steps (data not shown).
Total wall thickness, h/R, and vascular compliance.
There was a significant reduction in wall thickness and h/R values as transmural pressure increased in both veins and arteries (Table 2) . Mesenteric veins and arteries had similar wall thickness and h/R values at low and intermediate transmural pressures. However, at high transmural pressures, both wall thickness and h/R were greater in arteries compared with corresponding veins. The compliance (⌬ID/ ⌬P) of mesenteric veins was higher (17.45 Ϯ 1.38 m/mmHg, n ϭ 7) than the corresponding arteries (0.90 Ϯ 0.14 m/mmHg, n ϭ 5) (P Ͻ 0.05).
Effects of distending transmural pressure on contractile responses to NE and ET-1. Changes in mesenteric vessel ID as a function of NE and ET-1 contractile-responses were obtained at three levels of transmural pressure: low, intermediate, and high pressures (Figs. 5 and 6 ). NE and ET-1 caused dosedependent decreases in mesenteric vessel diameter. There was no significant difference in the sensitivity to NE or ET-1 contractile responses in mesenteric veins or arteries at the different pressure levels studied (Table 3) . However, as transmural pressure increased, there was a trend of enhanced contractile responses to NE and ET-1 in mesenteric veins, and to NE in mesenteric arteries, particularly with higher pressures. Mesenteric veins were more sensitive to NE and ET-1 when compared with corresponding arteries at low, intermediate, and high transmural pressures. Additionally, E max values attained with NE did not differ between mesenteric veins and arteries, whereas E max values for ET-1 CRCs were greater in veins compared with those obtained in arteries.
DISCUSSION
Vascular tone is regulated mainly by the sympathetic nervous system, myogenic reactivity, and local or systemic hormones (16, 32, 38) . Although the influence of these factors on overall vasomotor tone has been extensively studied in arteries (1, 2, 13, 25, 49), our study is the first to investigate mechanisms involved in the development of pressure-induced venomotor tone and its interaction with the endothelium and key vasoactive hormones, such as NE and ET-1 in a largecapacitance vascular bed like the mesentery.
Modulation of myogenic reactivity in mesenteric veins by the endothelium. In the present study, removal of the endothelium from the mesenteric vessels did not affect the characteristics (i.e., shape and slope) of the pressure-diameter curves, supporting the notion that the endothelium is not involved in the origin of myogenic reactivity in the mesenteric veins or arteries. Removal of the endothelium also produced no significant effect on the magnitude of the pressure-diameter curves, suggesting that it also has no overall modulatory role on myogenic reactivity in the mesenteric vessels under conditions of no flow. It is also possible that high intravascular pressures could have attenuated dilator responses in the mesenteric vessels in our study (14) . However, in our study, the integrity of the endothelium to agonist-evoked dilator release remained intact. Additionally, lack of modulatory effects of the endothelium on myogenic reactivity was also noted at lower pressures in both vessels. Therefore, our findings instead suggest limited contributions from basal release of endothelial dilators in pressurized mesenteric veins, and comparable arteries, under the experimental conditions of the present study. The absence of high distending pressures and pulsatile flow conditions in the physiological pressure range of most veins could explain a reduced need for constitutive dilator release in these vessels.
Because it is has been suggested that distending pressure may evoke endothelial release of a combination of constrictors and dilators that produce no net effect on myogenic reactivity Values are means Ϯ SE; n ϭ number per group in parenthesis. P Ͻ 0.05, †compared with medium and high transmural pressure within a vessel; ‡com-pared with high transmural pressure within a vessel; *compared with corresponding small artery.
Table 2. Wall thickness and wall-to-lumen ratio (h/R) values obtained from control pressure curves at low, intermediate, and high transmural pressures in mesenteric small arteries and veins isolated from normal male rats
following endothelium removal (37), we also evaluated the contribution of pressure-induced release of endothelial-derived NO to vasomotor tone. We found no significant effect of inhibition of NOS with L-NNA on pressure-diameter responses in either mesenteric vessels compared with control responses. Similar findings have also been reported in pressurized fourthorder rat mesenteric venules (4) .
Signaling mechanisms responsible for myogenic reactivity in mesenteric veins. It is established that VOCCs are important for cardiac myocyte and skeletal muscle contraction, with the L-type channel generally essential for arterial smooth muscle contraction (16, 30, 45, 50, 54, 56) . We found that activation of L-VOCCs accounts, in part, for the development of myogenic tone in mesenteric veins subjected to increasing transmural pressure. A weak role of these ion channels in the development of venous myogenic tone was also reported in rabbit facial veins, suggesting that this may be a general finding in veins (27) . Recent work by Thakali et al. (50) also supports the notion that pressurized mesenteric veins are resistant to calcium channel blocker-induced dilation. However, this group did not specifically examine myogenic reactivity or changing pressure conditions. Therefore, venous myogenic tone may be developed, in part, independently of L-VOCCs, suggesting that under physiological conditions, mesenteric veins may rely on other calcium sources, including other calcium channels or intracellular calcium.
Calcium sensitization of the VSM contractile apparatus via activation of PKC and Rho kinase molecules represents another key signaling pathway used to modify vasomotor tone (23) . PKC and Rho kinase are thought to act via inhibition of myosin light chain phosphatase, an enzyme involved in dephosphorylation of myosin light chain (58, 59) . While Rho kinase appears to phosphorylate myosin light chain phosphatase directly, PKC has been suggested to act indirectly, by increasing the activity of CPI-17 (PKC-activated protein phosphatase inhibitor of 17 kDa) (45) . We found that inhibition of Rho kinase by Y27632 (3 M) abolished myogenic reactivity in both mesenteric vessels at all transmural pressure steps. Additionally, we confirmed specificity of action of Y27632 at 3 M by demonstrating no significant effects of the inhibitor on NE or KCl responses in either mesenteric veins or arteries. The results obtained with the PKC inhibitor, chelerythrine, were less conclusive. While chelerythrine at 2.5 M largely abolished myogenic reactivity in both vessels at most pressure steps, it also attenuated NE and KCl responses in both veins and arteries, suggesting it may have acted in a nonspecific manner, in part, to affect vascular tone. However, it should be emphasized that in the presence of chelerythrine at 2.5 M, significant KCl-and NE-induced constriction still remained, while myogenic activity was absent, as evidenced by the fully distended vessels.
In a separate set of experiments, we also showed that chelerythrine at 1 M did not significantly affect contractile responses to NE or KCl, but also did not significantly alter myogenic reactivity in either vessel. Additionally, we showed that reductions in NE responses in the presence of chelerythrine at 2.5 M were significantly greater than corresponding reductions with KCl responses. These findings are in agreement with a demonstrated link of PKC to activation of the adrenergic pathway in VSM, while inhibition of K ϩ -depolarized VSM would imply a more general nonspecific effect on the vessels (35) . We therefore conclude that the absence of myogenic reactivity in the presence of chelerythrine at 2.5 M was not explained by the complete suppression of VSM contractility, but rather is due, in part, to the effects of PKC inhibition (53) .
Our results show a significant role for Rho kinase in myogenic reactivity in both vessels, while PKC may play a more widespread role in vascular tone development including myogenic reactivity. The work of others definitely supports the preservation of a key role for these molecules in pressureinduced tone in most vascular preparations, including pressurized rat mesenteric arteries and rabbit facial veins (8, 27, 28, 46, 51, 53, 55) . This highlights the important role played by calcium sensitization in myogenic reactivity of veins, which enables vessels to maintain a range of pressure-induced vascular tone without large changes in intracellular calcium (53) . Although most studies suggest that PKC and RhoA/Rho kinase pathways are activated independently to cause VSM contraction, cross talk between them has been suggested (35) . It is therefore conceivable that inhibition of each of these pathways, i.e., PKC or Rho kinase could produce substantial reductions in myogenic reactivity. One common link between the two pathways is CPI-17, which serves as a substrate for both Rho kinase and PKC, and whose actions prolong VSM contraction (45) .
Contractile responses to NE and ET-1 in pressurized mesenteric veins. Virtually no studies have been performed comparing interactions of vasoactive agonists with changing transmural pressure in veins, making comparisons with findings in our study challenging. Both NE and ET-1 are important humoral factors regulating vasomotor tone in the mesentery. Dornyei et al. (7) reported that pressure-induced contractions were enhanced in the low pressure range (0.5-2.0 mmHg) in rat skeletal (gracilis) muscle venules that were first preconstricted with NE, and then followed by increasing pressure steps (0.5-17.5 mmHg). Our results obtained by first fixing distending pressure and then generating concentration responses to agonists showed no significant difference in the sensitivity of mesenteric vessels to NE or ET-1 when compared across increasing transmural pressure; albeit a tendency of enhanced responses to NE and ET-1 was observed in the veins. It is possible that the different methodological approaches accounts for the inconsistent findings between ours and the former study. A more plausible explanation may lie with the differing vascular beds studied. Hindquarter skeletal muscle vasculature is characterized by steep concentration-resistance and pressurediameter relationships in response to vasoactive agonists and distending transmural pressures, respectively (5, 7, 47). Therefore, a greater resistance in the venular network of this vascular bed would be required to maintain the integrity of the microvasculature and facilitate venous return in response to exercise, postural changes, and hormones (31) . The degree of pressure changes experienced in vivo in the distal mesenteric arcade appears to be less, and the pressure gradient shallower, than those in the hindquarter skeletal muscle vasculature as it branches from the femoral artery (5, 11) . Therefore, the presence of a less-pronounced (magnitude and rate of gain) myogenic mechanism in the mesenteric arcade may be necessary to effectively autoregulate blood flow in this organ compared with the hindquarter gracilis muscle vasculature (7, 11, 22, 47) . Additionally, the mesenteric bed has a high level of sympathetic innervation with nerve density being greater in the veins given their reduced layers of VSM (24) . As such, interactions between myogenic reactivity and neurogenic influences that produce enhanced venomotor tone in the mesenteric veins may be detrimental to cardiovascular homeostasis. Therefore, moment-to-moment adjustments of sympathetic input to the mesenteric veins operating against a background of myogenic tone could conceivably offer the best means to maintain tight control over the balance of venous return and capacitance function in a vascular bed where small changes in venomotor tone have large hemodynamic consequences.
We also found that contractile responses to ET-1 and NE in mesenteric veins were significantly more sensitive than findings in comparable arteries across the range of low-to-high physiological pressures studied. The higher sensitivity of mesenteric veins to NE may due to contributions from larger numbers of ␣ 1 -adrenergic receptors compared with arteries (40); or to the involvement of ␣ 2 -adrenergic receptors in NE-induced venous constriction (41) . Contractile responses to Values are means Ϯ SE; n ϭ number per group in parenthesis. P Ͻ 0.05, *, †compared with corresponding small artery.
ET-1 in mesenteric arteries occurs via activation of VSM ET A receptors, while in veins activation of both VSM ET A and ET B receptors is possible (19, 20) . Taken together, these findings indicate that the increased sensitivity of mesenteric veins compared with arteries to either agonist in the present study is maintained when these vessels are pressurized across a range of physiological distending pressures. This finding has obvious relevance in vivo where vessels are subjected to a range of distending transmural pressures.
Perspectives and Significance
The mesenteric veins developed myogenic reactivity in the form of myogenic tone that appeared to be greatest over the low-to-intermediate range of physiological pressures studied. These findings highlight the potential importance of enhanced myogenic tone to overall venomotor tone at low-to-intermediate physiological distending pressures and their maintenance of adequate venous return in conjunction with input from other neurohormones, such as NE and ET-1, while reduced myogenic tone at higher distending pressures may conceivably aid the capacitance function of these vessels and prevent large shifts in blood to the heart. The lack of interactions between neurohormones and venous myogenic reactivity to enhance venomotor tone in a large capacitance bed like the mesentery is understandable given the strong potential for detrimental shifts in blood toward the heart.
Given the important role played by calcium sensitization in VSM, it is not surprising that the contribution of PKC and Rho kinase to myogenic reactivity is conserved across veins as well as arteries. Our study has provided a limited evaluation of the role of these molecules in the development of venous myogenic reactivity. However, a greater understanding of the role of these molecules is warranted, which will require additional studies. Our study also did not compare the relationship of venous myogenic characteristics across differing sizes of mesenteric veins. It is unknown whether pressure-induced myogenic reactivity increases in mesenteric veins with the order of generation of the vessel as has been found in mesenteric arteries (48) . Further studies exploring differences in mechanisms of pressure-induced myogenic reactivity in veins compared with arteries is of relevance for circulatory physiology and may reveal potential pharmacological targets that could be of therapeutic value in treatment of certain cardiovascular diseases marked by altered venous function.
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